Inventor
BOTTARO DONALD P
US16 patents
⚠️ This page may combine multiple inventors who share the name “BOTTARO DONALD P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
9 patentsUS6566098B1May 20, 2003
DNA encoding truncated hepatocyte growth factor variants
US HEALTH24 citations91
US5648273AJul 15, 1997
Hepatic growth factor receptor is the MET proto-oncogene
US HEALTH43 citations89
US6326466B1Dec 4, 2001
Double-stranded RNA dependent protein kinase derived peptides to promote proliferation of cells and tissues in a controlled manner
US HEALTH14 citations66
US11434268B2Sep 6, 2022
Vascular endothelial growth factor antagonists
US HEALTH0 citations60
US7132392B1Nov 7, 2006
Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain
US HEALTH2 citations55
US10035833B2Jul 31, 2018
Vascular endothelial growth factor antagonists and methods of making
US HEALTH0 citations50
US9550818B2Jan 24, 2017
Methods for use of vascular endothelial growth factor antagonists
US HEALTH0 citations50
US7605127B2Oct 20, 2009
Truncated hepatocyte growth factor variant protein HGF/NK2
US HEALTH0 citations45
US7871981B2Jan 18, 2011
Inhibition of cell motility, angiogenesis, and metastasis
US HEALTH0 citations42
BOTTARO DONALD P
4 patentsUS8304199B2Nov 6, 2012
Methods for diagnosing and monitoring the progression of cancer by measuring soluble c-Met ectodomain
BOTTARO DONALD P11 citations79
US8617831B2Dec 31, 2013
Methods for diagnosing and monitoring the progression of cancer by measuring soluble c-Met ectodomain
BOTTARO DONALD P11 citations76
US8569360B2Oct 29, 2013
Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling
BOTTARO DONALD P3 citations52
US8754081B2Jun 17, 2014
Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signaling
BOTTARO DONALD P0 citations41